1. Ximu Sun , Zhuo Ma , Qixiang Guo , Zhixia Zhao* , Lihong Liu *.Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System.Eur J Cancer.2022.160.277-278.SCI |
2. Xi Zhang , Zhuoling An , Yali Lv , Guangrun Li , Lihong Liu* , Pengfei Li *.Simultaneous Determination of RDX and HMX in Rat Plasma by LC-MS/MS and its Applications. Front Chem.2022.10.808226.SCI |
3. Jing Yang , Hui Yang , Zihui Wang , Xin Wang , Yingkai Wang , Xiaojia Yu , Lihong Liu*.Self-management among type 2 diabetes patients via the WeChat application: A systematic review and meta-analysis. J Clin Pharm Ther.2021.46(1).4-16.SCI |
4. Hui Yang, Yiqi Sun, Xiaojia Yu, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang,Lihong Liu*.Clinical impact of adaptation of initial tacrolimus dosing to CYP3A5 genotype after kidney transplantation: systematic review and meta–analysis of randomized controlled trials.Clinical Pharmacokinetics.2021.60(7).877-885.SCI |
5. Hui Yang†, Lizhen Pang†, Xiaopeng Hu, Wei Wang , Bifang Xu, Xiaodong Zhang, Lihong Liu* .Effectiveness and safety evaluation of thrice weekly double strength vs daily single strength trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia after kidney transplantation: a two year prospective cohort study.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES.2021.24.210-216.SCI |
6. Hao Liang #, Xinru Zhang#, Zhuo Ma#, Yan Sun, Chang Shu, Yihua Zhu, Yanwei Zhang, Songnian Hu*, Xiujuan Fu, Lihong Liu*.Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension.Pharmgenomics Pers Med.2021.14.189-197.SCI |
7. Pengfei Li#, Jun Peng#, Yuexin Li , Lili Gong, Yali Lv, He Liu, Tianhong Zhang, Song Yang, Hongchuan Liu, Jinglai Li*, Lihong Liu*.Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Finding Out the Causes Leading to the Ultra-low Oral Bioavailability and Identifying the Metabolic Pathway.Frontiers in Pharmacology.2021.12.621003.SCI |
8. Xin Wang, Shihui Wang, Xiaojia Yu, Zhuo Ma, Huaguang Wang, Jing Yang, Lihong Liu *..Impact of pharmacist-led medication therapy management in ambulatory elderly patients with chronic diseases..Br J Clin Pharmacol.2021.87(7).2937-2944.SCI |
9. Hui Yang, Chen Q, Huang A, Yu X, Chen G, Hu X, Wang W, Liu H, Zhang X, Liu L*. .The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES.2021.24.292-307.SCI |
10. Qixiang Guo#,Wenchao Lu#,Ximu Sun,Zhixia Zhao*,Lihong Liu*.Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients.European Journal of Cancer.2021.157.358-360.SCI |
11. Ximu Sun#, Xinrui Wang ,Jie Zhang ,Zhixia Zhao , Xin Feng *,Lihong Liu *, Zhuo Ma*.Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review..Breast.2021.60.26-34.SCI |
12. Zhuo Ma#, Ximu Sun#, Zhixia Zhao, Wenchao Lu, Qixiang Guo, Shihao Wang, Jiwen You, Yuhui Zhang*, Lihong Liu*.Risk of pneumonitis in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials and a pharmacovigilance study of the FAERS database.Gynecologic Oncology.2021.162(2).496-505.SCI |
13. Wenchao Lu#,Qixiang Guo#,Zhuo Ma,Lihong Liu*,Zhixia Zhao*.Lenvatinib and Osteonecrosis of the Jaw: A pharmacovigilance study.European Journal of Cancer.2021.150.211-213.SCI |
14. Zhuo Ma#, Ximu Sun#, Wenchao Lu, ZhiXia Zhao, Zhouming Xu, Jiayou Lyu, Peng Zhao, Lihong Liu*.Poly (ADP-ribose) Polymerase Inhibitors-Associated Myelodysplastic Syndrome/Acute Myeloid Leukemia: A Pharmacovigilance Study of the FAERS database.ESMO Open.2021.6(1).100033.SCI |
15. Pengfei Li, Xi Zhang, Shumin Wang, Jing Wang, Ziqi Liu, Chen Wang, Weihang Tong* and Lihong Liu*.Development of a rapid LC-MS/MS assay to determine letrozole in human plasma and its application in a pharmacokinetic study after oral administration.ACTA CHROMATOGRAPHICA.2021.34(2).179-184.SCI |
16. Ping Du*, Guoyong Wang, Rui Zhao, Zhuoling An, Lihong Liu*.Eicosanoids metabolomic profile of remdesivir treatment in rat plasma by high-performance liquid chromatography mass spectrometry..Front Pharmacol.2021.12.747450.SCI |
17. Han FF, Ren LL, Xuan LL, Lv YL, Liu H, Gong LL, An ZL, Liu LH*.HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer.Cancer Chemother Pharmacol.2021.87(1).103-112.SCI |
18. Rui Zhao# , Zhuoling An# , Yuan Sun , Liangyu Xia , Ling Qiu , Aimin Yao , Yanping Liu**, Lihong Liu*.Metabolic profiling in early pregnancy and associated factors of folate supplementation: A cross-sectional study.Clin Nutr.2021.40(9).5053-5061.SCI |
19. Ping Du, Guoyong Wang, Song Yang, Pengfei Li, Lihong Liu*.Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat.Analytical and Bioanalytical Chemistry.2021.413(23).5811-5820.SCI |
20. Song Yang, Ting Hu, He Liu, Ya-li Lv, Wen Zhang, Han Li, Lingling Xuan, Li-li Gong* , Li-hong Liu*.Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.Biomed Pharmacother.2021.138.111441.SCI |
21. Zhuo Ma, Shusen Sun , Caixai Zhang, Xiangzhi Yuan, Qing Chen , Jinling Wu , Xiaojuan Wang *, Lihong Liu*.Characteristics of drug-related problems and pharmacists' interventions in a geriatric unit in China.Int J Clin Pharm.2021.43(1).270-274.SCI |
22. Ying Wang, Zhikang Ye, Long Ge, Reed A C Siemieniuk, Xin Wang, Yingkai Wang, Liangying Hou, Zhuo Ma, Thomas Agoritsas, Per Olav Vandvik, Anders Perner, Morten H Møller, Gordon H Guyatt, Lihong Liu.Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.BMJ-British Medical Journal.2020.368.16744.SCI |
23. Zhikang Ye, Annika Reintam Blaser, Lyubov Lytvyn, Ying Wang, Gordon H Guyatt, J Stephen Mikita, Jamie Roberts, Thomas Agoritsas, Sonja Bertschy , Filippo Boroli, Julie Camsooksai, Bin Du, Anja Fog Heen, Jianyou Lu, José M Me.Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline.BMJ-British Medical Journal.2020.368.16722.SCI |
24. Hui Yang, Lizhen Pang, Xiaopeng Hu, Wei Wang, Bifang Xu, Xiaodong Zhang, Lihong Liu*.The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: a systematic review and meta-analysis.J Clin Pharm Ther.2020.45(3).488-495.SCI |
25. Yahui Yu#, Hui Yang#, Xiaojia Yu, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang, Xin Feng*, Lihong Liu*.Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument.Journal of Clinical Pharmacy and Therapeutics.2020.45(6).1325-1333.SCI |
26. Hui Yang#, Yahui Yu#, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang, Xin Feng, Lihong Liu*.Association Between the Overall Risk of Prostate Cancer and Calcium Channel Blockers use: A Systematic Review and Meta-Analysis.Clinical Therapeutics .2020.42(9).1715-1727.SCI |
27. Xin Wang, Shihui Wang, Jing Yang, Xiaojia Yu, Lihong Liu*.Genotype-guided antiplatelet therapy compared with standard therapy for patients with acute coronary syndromes or undergoing percutaneous coronary intervention: A systematic review and meta-analysis.Thromb Res.2020.193.130-138.SCI |
28. Xin Wang #, Hui Yang #, Shihui Wang, Xiaopeng Hu, Xiaojia Yu, Wei Wang, Xiaodong Zhang *, Lihong Liu *.Comparison of Effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis Running title: Abiraterone versus enzalutamide in mCRPC.Journal of pharmacy and pharmaceutical science.2020.23.451-461.SCI |
29. Li-li Gong*, Song Yang, Wen Zhang, Fei-fei Han, Ling-ling Xuan, Ya-li Lv, He Liu, Li-hong Liu*.Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS.Disease Markers.2020.2020.2020.SCI |
30. Li-li Gong*, Song Yang, Wen Zhang, Fei-fei Han, Ya-li Lv, Ling-ling Xuan, He Liu, Li-hong Liu*.Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC–MS based lipidomics approach.Journal of Pharmaceutical and Biomedical Analysis.2020.177.112848.SCI |
31. Xin Wang, Jing Yang, Xiaojia Yu, Zihui Wang, Huaguang Wang, Lihong Liu*.Characterization of drug-related problems and associated factors in ambulatory patients in China.J Clin Pharm Ther.2020.45(5).1058-1065.SCI |
32. Lifang Guo#, Shumin Wang#, Zirui Wan#, Siyang Ni, Benshan Xu, Xiuli Zhao*,Lihong Liu*.Influence of CYP2D6*5 and *10 polymorphism on the pharmacokinetics of nebivolol in healthy Chinese subjects..Journal of Clinical Pharmacy and Therapeutics.2020.45(4).632-637.SCI |
33. Lulu Ren, Lingling Xuan, Feifei Han, Jie Zhang, Lili Gong, Yali Lv, Wen Zhang, Song Yang, Benshan Xu, Yan Yan, Lifang Guo, He Liu, Zirui Wan*, Lihong Liu*.Vitamin D supplementation rescues simvastatin induced myopathy in mice via improving mitochondrial cristae shape.Toxicology and Applied Pharmacology.2020.401.115076.SCI |
34. Zirui Wan#*, Lifang Guo#, Pengfei Li#, Zhixia Zhao, Benshan Xu, Lulu Ren, Yan Yan, He Liu, Yiwen Zhang*, Lihong Liu*.Determinants of Gefitinib Pharmacokinetics in Healthy Chinese Male Subjects: A Pharmacogenomic Study of Cytochrome p450 Enzymes and Transporters.Journal of Clinical Pharmacy and Therapeutics.2020.45(5).1159-1167.SCI |
35. Ting Hu#, Zhuoling An#, Yongkun Sun, Xunqiang Wang, Ping Du, Pengfei Li, Yihebali Chi*, Lihong Liu*.Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy and Toxicity.Frontiers in Oncology.2020.2020.2373.SCI |
36. Boyu Li, Yanjin Hu, Guang Wang*, Lihong Liu*.The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study.BMC pharmacology & toxicology.2020.21(1).1-6.SCI |
37. Lingling Xuan, Lulu Ren, Feifei Han, Lili Gong, Zirui Wan, Song Yang, He Liu, Yali Lv*, Lihong Liu*.Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production.Inflammation.2020.43(1).326-335.SCI |
38. Ting Hu#, Zhuoling An#, Chen Shi, Pengfei Li, Lihong Liu*.A sensitive and efficient method for simultaneous profiling of bile acids and fatty acids by UPLC-MS/MS.J Pharm Biomed Anal.2020.178.112815.SCI |
39. Ping Du, Ting Hu, Zhuoling An, Pengfei Li, Lihong Liu*.Simultaneous quantitative determination of arachidonic acid and cascade metabolites in rat serum by UPLC-MS/MS: application for longitudinal metabolomics of anlotinib.Analyst.2020.145(14).4972-4981.SCI |
40. Ping Du, Pengfei Li, Hongchuan Liu, Rui Zhao, Zhixia Zhao, Weiyue Yu, Xin Zhou, Lihong Liu*.Open-Label, Randomized, Single-Dose, 2-Period, 2-Sequence Crossover, Comparative Pharmacokinetic Study to Evaluate Bioequivalence of 2 Oral Formulations of Olanzapine Under Fasting and Fed Conditions.Clinical pharmacology in drug development.2020.9(5).621-628.SCI |
41. Ya-li Lv, Yangjie Jia, Zirui Wan, Zhuo-ling An, Song Yang, Fei-fei Han, Li-li Gong, Ling-ling Xuan, Lu-lu Ren, Wen Zhang, He Liu*, Li-hong Liu*.Curcumin inhibits the formation of atherosclerosis in ApoE-/- mice by suppressing human cytomegalovirus activity in endothelial cells.Life Sciences.2020.257.117658.SCI |
42. Lingling Xuan, Feifei Han, Lili Gong, Yali Lv, Zirui Wan, He Liu, Lulu Ren, Song Yang, Wen Zhang, Ting Li, Chunting Tan, Yuan Sun, Benshan Xu, Lihong Liu*.Ceramide Induces MMP-9 Expression Through JAK2/STAT3 Pathway in Airway Epithelium.Lipids Health Dis.2020.19(1).196.SCI |
43. Zhuo Ma#, ZhiXia Zhao#, ShuSen Sun, YiFan Li, ZhuoLing An, Yan Yan, LiHong Liu*.Impact of Chief Pharmacist System on drug expenditures and rational drug use.International Journal of Clinical Pharmacy.2020.42(1).167-173.SCI |
44. Zhuo Ma, YaLan Tong , Caixai Zhang, Lihong Liu*.Potentially inappropriate medications and potentially prescribing omissions in Chinese older patients: Comparison of two versions of STOPP/START..J Clin Pharm Ther.2020.45(6).1405-1413.SCI |
45. Yali Lv, Fei-fei Han, Zhuo-ling An, Yangjie Jia, Ling-ling Xuan, Li-li Gong, Wen Zhang, Lu-lu Ren, Song Yang, He Liu*, Li-hong Liu*.Cytomegalovirus infection is a risk factor in gastrointestinal cancer: a cross-sectional and meta-analysis study.Intervirology.2020.63(1-6).10-16.SCI |
46. Dan Liu#, Zhuoling An#, Pengfei Li, Yanhua Chen, Ruiping Zhang, Lihong Liu*, Jiuming He*, Zeper Abliz.A targeted neurotransmitter quantification and nontargeted metabolic profiling method for pharmacometabolomics analysis of olanzapine by using UPLC-HRMS.RSC Advances.2020.10.18305-18314.SCI |
47. Ping Du, Ting Hu, Zhuoling An, Pengfei Li, Lihong Liu*..In vitro and in vivo synergistic efficacy of ceritinib combined with programmed cell death ligand-1 inhibitor in anaplastic lymphoma kinase-rearranged non-small-cell lung cancer.Cancer Science.2020.111(6).1887-1898.SCI |
48. Fei-fei Han#, Hua Fan#, Lu-lu Ren, Hua-guang Wang, Chunlin Wang, Ma Xu*, Li-hong Liu*, Qiang He*, Chang-long Guo*.Profiling the pattern of human TRB/IGH‐CDR3 repertoire in liver transplantation patients via high‐throughput sequencing analysis.Scandinavian Journal Of Immunology .2020.92(2).e12912.SCI |
49. Huaguang Wang, Han Wang, Xiaojia Yu, Hong Zhou, Boyu Li, Gang Chen, Zhikang Ye, Ying Wang, Xiangli Cui, Yunying Zheng, Rui Zhao, Hui Yang, Zihui Wang, Peng Wang, Chunxia Yang, Lihong Liu*.Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study.BMJ Open.2019.9(8).e026072.SCI |
50. Wen Zhang, Lili Gong, Song Yang, Yali Lv, Feifei Han, He Liu, Lihong Liu*.Lipidomics Profile Changes of Type 2 Diabetes Mellitus with Acute Myocardial Infarction.Analytical methods.2019.2019.doi:10.1155/2019/7614715.SCI |
51. Song Yang, Wen Zhang, Ling-ling Xuan, Fei-fei Han, Ya-li Lv, Zi-rui Wan, He Liu, Lu-lu Ren, Li-li Gong∗, Li-hong Liu*.Akebia Saponin D inhibits the formation of atherosclerosis in ApoE-/- mice by attenuating oxidative stress-induced apoptosis in endothelial cells.Atherosclerosis.2019.285.23-30.SCI |
52. Lifang Guo*, Zuogang Li , Benshan Xu , Min Yu, Yan Fu, Lihong Liu*, Junzhi Wang*, Yongzhang Luo* .Pharmacokinetics of PEGylated Recombinant Human Endostatin in Rhesus Monkeys .Life Sci.2019.238.116867.SCI |
53. Jiaming Fan#, Pengfei Li#, He Liu, Rui Zhao, Zhixia Zhao, Ping Du, Lihong Liu*.Optimized liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of paraquat in plasma: application to a toxicokinetic study.Analytical methods.2019.11(21).2756-2762 .SCI |
54. Lifang Guo, Mingbiao Shi, Nan Song, Zirui Wan, He Liu*, Lihong Liu*.Anchorage of curcumin onto PVP enhances anti-tumor effect of curcumin.Medicinal Chemistry Research.2019.28(5).646-656.SCI |
55. Lifang Guo*, Benshan Xu, Daifu Zhou, Guodong Chang, Yan Fu, Lihong Liu*, Yongzhang Luo*.Biophysical and biological characterization of PEGylated recombinant human endostatin..Clin Exp Pharmacol Physiol.2019.46(10).920-927.SCI |
56. Li-li Gong, Song Yang, He Liu, Wen Zhang, Lu-lu Ren, Fei-fei Han, Ya-li Lv, Zi-Rui Wan, Li-hong Liu*.Anti-nociceptive and anti-inflammatory potentials of Akebia saponin D.Eur J Pharmacol.2019.845.85-90.SCI |
57. Ying Wang, Zhikang Ye, Lihong Liu*, Xiangli Cui*.Antidepressant Use and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis.J Pharm Pharm Sci.2019.21(1).57-71.SCI |
58. Hui Yang, Lili Li, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang*, Lihong Liu*.Impact of pharmacist-led post-transplant medication management for kidney transplant recipients: A retrospective pre- and post-intervention study.J Clin Pharm Ther.2019.44(4).603-610.SCI |
59. Xiangli Cui, Zirui Wan, Zhuo Ma, Lihong Liu*, Yuanhua Yang*.Occurrence of acute pulmonary embolism induced by recombinant erythropoietin during treatment of pure red cell aplasia associated with thymoma: A case report..Medicine (Baltimore).2019.98(10).e14789.SCI |
60. Lulu Ren, Feifei Han, Lingling Xuan, Yali Lv, Lili Gong, Yan Yan, Zirui Wan, Lifang Guo, He Liu, Benshan Xu, Yuan Sun,Song Yang, Lihong Liu*.Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation.Free Radical Biology and Medicine.2019.145.357-373.SCI |
61. Lifang Guo, Zirui Wan, Benshan Xu, Lulu Ren, He Liu, Nan Song*, Lihong Liu*.Blockade of angiogenin by thalidomide inhibits the tumorigenesis of murine hemangioendothelioma.Fundam Clin Pharmacol.2019.33(6).659-669.SCI |
62. 刘洪川,李鹏飞,杜 萍,于伟越,赵 瑞,刘丽宏*.用HPLC-MS/MS法测定人尿液中依普利酮的浓度.药学服务与研究. .2018.18(1).29-32.核心期刊 |
63. 田艳平,崔向丽,刘丽宏*.基于决策树模型对我国6种保肝药物治疗药物性肝损伤的成本-效果分析.中国药物应用与监测 .2018.15(3).131-135.核心期刊 |
64. 郑芸颖,崔向丽,刘丽宏*.酚磺乙胺注射液引发呼吸困难等过敏反应的案例分析 .中国临床药理学杂志.2018.34(13) .348-349.核心期刊 |
65. 刘洪川,李鹏飞,杜 萍,赵 瑞,于伟越,刘丽宏*.高效液相色谱-质谱联用法测定人血浆中依普利酮浓度.中国临床药理学杂志 .2018.34(10) .1226-1229.核心期刊 |
66. 范家明,刘河,李鹏飞,赵瑞,刘丽宏*.血浆、尿液中百草枯定量检测方法研究进展.国际检验医学杂志.2018.39(14).1753-1756.核心期刊 |
67. 安卓玲,李超,吕亚丽,李鹏飞,吴诚,刘丽宏*.Metabolomics of hydrazine-induced hepatotoxicity in rats for discovering potential biomarkers.Disease Markers.2018.2018.8473161.SCI |
68. 安卓玲,李超,吕亚丽,李鹏飞,吴诚,刘丽宏*.Metabolomics of hydrazine-induced hepatotoxicity in rats for discovering potential biomarkers.Disease Markers.2018.2018.8473161.SCI |
69. 赵志霞,宋 新,李鹏飞,赵 瑞,于伟越,周 鑫,刘丽宏*.生物等效性试验中受试者食用高脂餐的调查研究.中国临床药理学杂志 2018 .2018.34(24) .85-87.核心期刊 |
70. 董亚玲#, 吕亚丽#, 周晓金#, 何林富#, 刘丽宏*, 李鹏飞.Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers.OncoTargets and Therapy .2018.11.1743–1756 .SCI |
71. 李博宇、王颖、叶志康、杨辉、崔向丽、王振军*、刘丽宏*.Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials .J Pharm Pharm Sci.2018.21(1).25-235 .SCI |
72. 宫丽丽、杨嵩、张文、韩菲菲、吕亚丽、万子睿、刘河、贾阳杰、玄玲玲、刘丽宏*.Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy .Journal of Pharmacological Sciences.2018.136(4).189-195.SCI |
73. 陈罡,潘世芬,崔向丽,刘丽宏* .Puerarin attenuates angiotensin II-induced cardiac fibroblasts proliferation via the promotion of catalase activity and the inhibition of hydrogen peroxide-dependent Rac-1 activation.Chinese Journal of Natural Medicines .2018.16(1) .41-52.SCI |
74. 杨辉,王伟,胡小鹏,张小东*,刘丽宏*.Sirolimus-induced severe small bowel angioedema:A case report .Medicine .2018.97(34).e12029.SCI |
75. Han FF, Lv YL, Gong LL, Liu H, Wan ZR, Liu LH..VDR Gene variation and insulin resistance related diseases..Lipids Health Dis.2017.16(1).157.SCI |
76. 王鑫,杨辉,刘丽宏*.1例黄体酮诱发急性胰腺炎的药学监护.中国临床药理学杂志.2017.33(7).647-648.核心期刊 |
77. 王子惠,崔向丽,刘丽宏*.草木犀流浸液片与华法林联合应用致INR快速升高3例.中国药物警戒杂志.2017.14(11).637-9.核心期刊 |
78. Li-li Gong, Fei-fei Han, Ya-li Lv, He Liu, Zi-rui Wan, Wen Zhang, Ming-biao Shi, Li-xia Pei, Li-hong Liu*.TNF-alpha and LT-alpha polymorphisms and the risk of leukemia: a meta-analysis..TUMORI.2017.103(1).53-59.SCI |
79. 崔向丽,王诗卉,刘丽宏*.案例教学法在临床药师实习教学中的应用.中国临床药理学杂志.2017.33(7).659-661.核心期刊 |
80. 郑芸颖,崔向丽,刘丽宏*.药物引发血小板严重减少症 1 例.临床药物治疗杂志 .2017.15(3).64-66.核心期刊 |
81. 李博宇,崔向丽,邱爽,刘丽宏*.胸腺五肽注射液不合理用药干预分析.中国临床药理学杂志.2017.33(7).653-655.核心期刊 |
82. 王华光,刘丽宏*.临床药师参与一例肝移植术后病人的多学科会诊.药学服务与研究.2017.17(5).343-346.核心期刊 |
83. Ya-li Lv, Fei-fei Han, Li-li Gong, He Liu, Jun Ma, Wei-yue Yu, Zi-rui Wan, Yang-jie Jia, Wen Zhang, Mingbiao Shi, Li-hong Liu*.Human cytomegalovirus infection and vascular disease risk: A meta-analysis.Virus Research.2017.227.124-134.SCI |
84. 王颖、叶志康、崔向丽、刘丽宏*.1例奥美拉唑或奥曲肽致肝损伤的药学监护.中国临床药理学杂志.2017.33(19).1959-1960.核心期刊 |
85. 王颖、叶志康*、崔向丽、刘丽宏*.2例PCI术后患者抗血小板治疗的药学监护.药物流行病学杂志.2017.26(5).364-366.核心期刊 |
86. 杨 婧,崔向丽,杨 辉*,刘丽宏*.临床药师对1例肾移植术后患者的药物治疗方案优化.药学与临床研究杂志.2017.25(4).348-350.核心期刊 |
87. 王鑫,崔向丽,刘丽宏*.临床药师对高血压患者个体化用药的药学实践.实用药物与临床.2017.20(6).705-707.核心期刊 |
88. 王鑫,崔向丽,杨辉*,刘丽宏*.肾移植术后尿路感染病原菌及抗感染治疗方案分析.中国医院药学杂志.2017.37(12).1195-1198.核心期刊 |
89. 王子惠, 崔向丽, 杨辉, 刘丽宏*.肾移植术后1例患者的药学监护.中国临床药理学杂志.2017.33(11).1024-5.核心期刊 |
90. Xin Wang, Hui Yang, Xiaodong Zhang, Xiangli Cui, Shihui Wang, Lihong Liu*.Effectiveness of Valganciclovir 900mg Versus 450mg for Cytomegalovirus Prophylaxis in Renal Transplantation: A Systematic Review and Meta-Analysis .J Pharm Pharm Sci.2017.20.168-183.SCI |
91. Yang-jie Jia, Jun Liu, Fei-fei Han, Zi-rui Wan, Li-li Gong, He Liu, Wen Zhang, Thomas Wardell, Ya-li Lv*,, Li-hong Liu* .Cytomegalovirus infection and atherosclerosis risk: a meta-analysis .J Med Virol.2017.89(12).2196-2206.SCI |
92. 郭梦园,崔向丽,刘丽宏*,刘莹.3例精准用药门诊药物治疗管理案例分析.实用药物与临床杂志.2017.20(2).236-240.核心期刊 |
93. 马卓,崔向丽*,刘丽宏*.精准用药门诊1例低钠血症患者的药物治疗管理.中国新药杂志.2017.26(7).837-840.核心期刊 |
94. 杨婧, 杨辉, 刘丽宏*.1 例嗜铬细胞瘤患者的药学监护.临床药物治疗杂志.2017.15(8).69-71.核心期刊 |
95. 侯珂露,杨辉,叶志康,王颖,刘丽宏*,崔向丽.Effectiveness of Pharmacist-led Anticoagulation Management on Clinical Outcomes: A Systematic Review and Meta-Analysis.Journal of Pharmacy & Pharmaceutical Sciences.2017.20.378-396.SCI |
96. Ya-li Lv, Fei-feiHan,Li-li Gong,HeLiu,JunMa,Wei-yueYu,Zi-ruiWan,Yang-jieJia,Li-hong Liu* .Human cytomegalovirus infection and vascular disease risk:A meta-analysis.Virus Research.2017.227(2017).123-134.SCI |
97. Yang, Xiangli Cui, Xin Wang, Shuang Qiu, Lihong Liu*..Clinical Outcomes with Antiviral Prophylaxis or Preemptive Therapy for Cytomegalovirus Disease after Liver Transplantation: A Systematic Review and Meta-Analysis.J Pharm Pharm SciHui .2017.20(1).15-27.SCI |
98. 杨辉,崔向丽,刘丽宏*.临床药师对1例腹膜透析相关性腹膜炎患者的药学监护.中国临床药理学杂志.2017.(01).67-69.核心期刊 |
99. 杨辉,尹航,崔向丽,刘丽宏*.临床药师用药教育对患者获益影响的系统评价与Meta分析.中国新药杂志.2017.(07).831-836.核心期刊 |
100. 李博宇,计成,崔向丽,葛卫红,刘丽宏*.1例甲状腺乳头状癌术后患者左甲状腺剂量调整分析.中国临床药理学杂志.2017.33(15).97-99.核心期刊 |
101. 于晓佳,崔向丽*,刘莹,杨辉,邱爽,陈罡,叶志康,刘丽宏.新医改形势下药学服务模式的转变与实践.中国临床药理学杂志.2017.33(11).1042-1044.核心期刊 |
102. Li P, Hoppmann S, Du P, Li H, Evans PM, Moestue SA, Yu W, Dong F, Liu H, Liu L*..Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers.Ultrasound Med Biol.2017.43(5).1031-1039.SCI |
103. 郭梦园,崔向丽,刘丽宏*.抗凝药物防治骨科大手术患者深静脉血栓形成的研究进展.中国临床药理学杂志.2016.(16).1523-1526.核心期刊 |
104. 陈慧,刘河,安卓玲,崔向丽,苏晔,张东肃,刘丽宏*.全国18个省市63家医疗机构药品短缺的调查分析及应对思考.药学服务与研究.2016.(05).331-334.核心期刊 |
105. 马卓,崔向丽,刘丽宏*.硫酸镁治疗成人哮喘急性发作的系统评价(英文).ournal of Chinese Pharmaceutical Sciences.2016.(08).621-631.核心期刊 |
106. Zhi-Kang Ye, Ying Liu, Xiang-Li Cui, Li-Hong Liu*.Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis.PLo S ONE.2016.11(5).e0155020.SCI |
107. Hui Yang, Xiangli Cui, Zhuo Ma, Lihong Liu*.Evaluation Outcomes Associated with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis.J Pharm PharmSci.2016.19(2).274-289.SCI |
108. Gong LL,Han FF, Lv YL, Liu H, Wan ZR, Zhang W,ShiMB,PeiLX,Liu LH*.TNF-α and LT-α polymorphisms and the risk of leukemia: a meta-analysis.Tumori.2016.103(1).53-59.SCI |
109. Gong LL, Liu H, Liu LH*.Relationship between hypothyroidism and the incidence of gestational diabetes: A meta-analysis.Taiwan J Obstet Gynecol.2016.55(2).171-175.SCI |
110. Gong LL, Li GR, Zhang W, Liu H, Lv YL, Han FF, Wan ZR, Shi MB, Liu LH*.AkebiaSaponin D Decreases Hepatic Steatosis through Autophagy Modulation.J Pharmacol Exp Ther.2016.359(3).392-400.SCI |
111. 苏晔,马卓,杨梅,赵志霞,刘丽宏*.北京朝阳医院门诊药房5714例处方干预情况分析.临床药物治疗杂志.2016.(02).9-12.核心期刊 |
112. 杨辉,徐晨,马卓,刘丽宏*.静脉注射头孢西丁致凝血功能障碍1例.药学与临床研究.2016.(03).263.核心期刊 |
113. 郭梦园,崔向丽,刘丽宏*,尹博,单磊.老年髋部骨折术前下肢深静脉血栓形成高危因素及抗凝治疗分析.中国骨与关节损伤杂志.2016.(12).1268-1271.核心期刊 |
114. 王鑫,崔向丽,杨辉,刘丽宏*.肾移植术后医院感染病原菌及抗感染治疗方案分析.药学与临床研究.2016.24(06).475-478.核心期刊 |
115. 王鑫,杨辉,崔向丽,刘丽宏*.肾移植受者围手术期感染的危险因素分析.中国临床药理学杂志.2016.32(23).2129-2131.核心期刊 |
116. 王华光,冯频频,宫丽丽,刘河,刘丽宏*.2012-2013年病原菌分布与对抗菌药物的药敏分析.中华医院感染学杂志.2016.(01).52-55.核心期刊 |
117. 刘莹,崔向丽,刘丽宏*.临床药师在骨科老年患者中的药物重整实践.中国医院药学杂志.2016.(09).766-770.核心期刊 |
118. 安卓玲,苏晔,张东肃,刘河,刘丽宏*.医院药学教学培训模式的探索实践.中国病案.2016.(07).93-96.核心期刊 |
119. 邸宣,邱爽,刘丽宏*.成人腹股沟疝术后慢性疼痛研究.临床药物治疗杂志.2015.(05).57-61.核心期刊 |
120. 崔向丽,林松,邱爽,张征,刘丽宏*.外科临床药师参与术后抗感染会诊的实例分析.中国临床药理学杂志.2015.(19).1968-1970.核心期刊 |
121. YALI LV, LILI GONG, ZIHUI WANG, FEIFEI HAN, HE LIU, XUECHUN LU, LIHONG LIU*.Curcumin inhibits human cytomegalovirus bydownregulating heat shock protein 90 .MOLECULAR MEDICINE REPORTS.2015.12(3).4789-4793.SCI |
122. Gang Chen, Qiang Cao, Xiangli Cui, Shifen Pan, Chong Shen, Lihong Liu*.Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.Journal of pharmacy and pharmaceutical sciences.2015.18(2).235-248.SCI |
123. 刘莹,崔向丽,刘丽宏*.国内外药物重整研究进展.中国药学杂志.2015.(24).2099-2102.核心期刊 |
124. 王华光,王颖,刘丽宏*.2008-2013年北京医疗机构中低分子量肝素不良反应分析.药学服务与研究.2015.(05).366-369.核心期刊 |
125. 刘莹,崔向丽,刘丽宏*.骨科术后感染危险因素及抗感染治疗方案探讨.临床药物治疗杂志.2015.(02).53-58.核心期刊 |
126. 陈慧,刘丽宏*.台湾地区医院药学模式介绍及对大陆地区的启示.中国药房.2014.25(9).785-787.核心期刊 |
127. 李广润,宫丽丽,吕亚丽,刘河,韩菲菲,王子惠,刘丽宏*.川续断皂苷VI对非酒精性脂肪肝小鼠的降脂作用研究.时珍国医国药.2014.25(8).1800-1802.核心期刊 |
128. 李广润,宫丽丽,吕亚丽,刘丽宏*.川续断皂苷Ⅵ药理作用研究进展.中国新药与临床杂志.2014.33(7).477-480.核心期刊 |
129. Lv Y, An Z, Chen H, Wang Z, Liu L*.Mechanism of curcumin resistance to human cytomegalovirus in HELF cells.BMC Complement Altern Med .2014.14.284.SCI |
130. Gong LL, Liu H, Liu LH*.Lack of association between matrix metalloproteinase-9 gene-1562C/T polymorphism and preeclampsia: a meta-analysis.Hypertens Pregnancy.2014.33(4).388-394.SCI |
131. Han FF, Fan H, Wang ZH, Li GR, Lv YL, Gong LL, Liu H, He Q*, Liu LH*.Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft.Transpl Immunol.2014.31(2).81-86.SCI |
132. 王子惠,韩菲菲,刘丽宏*.孕期服用抑酸药与后代发生儿童哮喘关系的Meta分析.实用临床医药杂志.2014.18(19).88-90.核心期刊 |
133. 王华光,刘丽宏*.临床药师参与抗菌药物使用管理的经验和体会.药学服务与研究.2014.14(2).101-103.核心期刊 |
134. Gong LL, Wang ZH, Li GR, Liu LH*.Protective Effects of Akebia Saponin D Against Rotenone-Induced Hepatic Mitochondria Dysfunction.J Pharmacol Sci.2014.126(3).243-252.SCI |
135. 李鹏飞, 王淑民, 张茜,安卓玲, 刘丽宏*.LC-MS/MS法测定人血浆中氨基葡萄糖的浓度.首都医科大学学报.2013.34(5).715-719.核心期刊 |
136. 路敏, 雷宁, 吕亚丽, 吴诚, 李超, 刘丽宏*.续断皂苷类成分的体外抗氧化活性研究.北京师范大学学报:自然科学版.2013.49(1).42-45.核心期刊 |
137. 张征, 刘颖, 张倩, 刘丽宏*.荧光素钠注射液致不良反应55例分析.中国药房.2013.24(44).4189-4191.核心期刊 |
138. 张征, 李馨,李鹏飞, 于晓佳, 邱葵, 罗薇, 刘丽宏*.中毒患者血浆中百草枯的LC-MS/MS定量检测方法研究.国际检验医学杂志.2013.34(11).1380-1381.核心期刊 |
139. 罗薇, 王鹤尧*, 刘丽宏*,李鹏飞, 祝锦, 宫丽丽.CYP2C19多态性对奥美拉唑药代动力学的影响.临床药物治疗杂志.2013.11(2).22-26.核心期刊 |
140. 陈慧, 童卫杭, 刘丽宏*.盐酸吉西他滨致手足综合征1例.中国医院药学杂志.2013.33(9).755-756.核心期刊 |
141. 张茜, 李鹏飞, 吕亚丽, 安卓玲, 吴诚, 李广润, 刘丽宏*.硝胺推进剂在大鼠体内代谢动力学及病理学研究.国际检验医学杂志.2013.34(3).263-265.核心期刊 |
142. Li-Li Gong, Lian-Hua Fang, He-Yao Wang, Jian-Hao Peng, Kun Si, Jin Zhu, Fei-Fei Han, Yue -Hua Wang, Guan-Hua Du*, Li-Xia Pei, Li-Hong Liu*.Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.Steroid.2013.2013(78).401-408.SCI |
143. Pengfei Li, Beibei Tao, Xude Zhang,Zhuoling An, Xi Zhang, Yue Li, Hao Qianqian, Lihong Liu*.High-flux Detection of 30 Kinds Amino Acids with Isotope-Labeled Internal Standard by LC-MS/MS.Chinese Journal of Analytical Chemistry.2013.41(9).1347-1352.SCI |
144. Fei-fei Han, Chang-long Guo, Li-hong Liu*.The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis.DNA and Cell Biology.2013.32(6).329-335.SCI |
145. Fei-fei Han, Chang-long Guo, Li-Li Gong, Jin Zhu, Li-hong Liu*.Effects of the NQO1 609C>T Polymorphism on Leukemia Susceptibility: Evidence from a Meta-analysis.Asian Pacific Journal of Cancer Prevention.2013.14(9).5311-5316.SCI |
146. 王波, 李鹏飞, 马萍,王燕, 刘丽宏*.LC-MS/MS和荧光偏振法监测环孢素A血药浓度的相关性研究.质谱学报.2012.33(1).28-31.核心期刊 |
147. 蓝苑元, 罗恋, 吕亚丽, 马萍, 刘丽宏*.姜黄素自微乳化制剂制备及其稳定性研究.中国药师.2012.15(2).173-177.核心期刊 |
148. 童卫杭, 温洁怡, 宝玉荣,李鹏飞, 马萍, 王燕, 刘丽宏*.来曲唑片在中国健康人体的生物等效性.中国临床药理学杂志.2012.28(2).131-134.核心期刊 |
149. 雷宁, 王玲, 孙健姿, 吴诚, 刘丽宏*.六味参苓颗粒的质量标准研究.中国药房.2012.23(35).3328-3330.核心期刊 |
150. 李超, 张晓菲, 吕亚丽, 蓝苑元, 雷宁, 刘丽宏*.木通皂苷D对CCl4致小鼠急性肝损伤的保护作用.华西药学杂志.2012.27(3).257-259.核心期刊 |
151. Peng -Fei Li, Jian-Zi Sun, Ling Wang, Ya-Li Lv, Li-Hong Liu*.3,5-Bis(adamantan-1-yl)-1 -methoxy-benzene.Acta Crystallographica Section E.2012.E68.01182.SCI |
152. 吴诚, 李鹏飞,王燕, 雷宁, 吕亚丽, 刘丽宏*.液相色谱-质谱联用法测定大鼠血浆中木通皂苷D的浓度.国际药学研究杂志.2012.39(3).261-264.核心期刊 |
153. 王燕, 李鹏飞, 马萍, 安卓玲, 张茜,罗恋, 刘丽宏*.LC-MS/MS法测定人血浆中氨氯地平的浓度.质谱学报.2012.33(3).181-185.核心期刊 |
154. 马萍, 李鹏飞, 王淑民, 汪娟, 王燕, 谢晓娟, 刘丽宏*.克拉霉素软胶囊在中国健康人体的生物等效性研究.中国临床药理学与治疗学.2012.17(4).433-437.核心期刊 |
155. 李鹏飞, 孙健姿, 马萍, 王燕, 王静, 张茜, 谢小娟, 刘丽宏*.LC-MS/MS法测定人血浆中克拉霉素的质量浓度.北京师范大学学报:自然科学版.2012.48(4).323-326.核心期刊 |
156. 马萍, 李鹏飞, 童卫杭, 孙健姿, 吴诚, 刘丽宏*.氯沙坦钾片在健康人体的生物等效性.中国临床药理学杂志.2012.28(3).179-182.核心期刊 |
157. 李鹏飞, 王燕, 童卫杭, 马萍, 兰安杰, 刘丽宏*.液相色谱-串联质谱法测定人血浆中多潘立酮浓度..中国临床药理学杂志..2012.28(3).208-211.核心期刊 |
158. Ya-li LV, An-jie LAN, Yuan-yuan LAN, Chao LI, Ning LEI, Cheng WU and Li-hong LIU*.Activity of curcumin against human cytomegalovirus in vitro.African Journal of Pharmacy and Pharmacology..2012.6(1).30-35.SCI |
159. Kang Meng, Miao Cao, Zhuo-Ling An, Jie Zhang, Li-Hong Liu*.(5-Bromo-2-hydroxyphenyl)(4-propyl-cyclohexyl) methanone.Acta Crystallographica Section E.2012.E68.01181.SCI |
160. Li-Li Gong, Jian-Ha oPeng, Fei-Fei Han, Jin Zhu, Lian-Hua Fang, Yue-Hua Wang, Guan-Hua Du*, He-Yao Wang*, Li-Hong Liu*.Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.Thrombosis Research.2012.130(3).e43-51.SCI |
161. 吕亚丽, 蓝苑元, 王丹, 雷宁, 刘丽宏*.姜黄素体外抗人巨细胞病毒活性的研究.中药新药与临床药理.2012.23(5).531-533.核心期刊 |
162. 安卓玲, 李鹏飞, 迟小华, 张茜, 马萍, 刘丽宏*.肼引发损伤相关小分子代谢物的研究进展.中国药理学通报.2012.28(6).754-756.核心期刊 |
163. 王燕, 李鹏飞, 马萍, 安卓玲, 胡范文, 刘丽宏*.LC-MS/MS法检测他克莫司血药浓度室内质控回顾性分析.国际检验医学杂志.2012.33(15).1873-1875.核心期刊 |
164. Pengfei Li, Yan Wang, Beibei Tao, Jing Wang, Jing Luo, Xude Zhang, Zhuoling An, Lihong Liu*.Simultaneous Determination of 42 Amino Acids in Human Body by Stable Isotope Isobaric Tage for Relative and Absolute Quantitation Labeled-LC-MS/MS with Typical Example Cases.Chinese Journal of Analytical Chemistry.2012.40(5).762-767.SCI |
165. 郑芸颖,王华光,崔向丽,刘丽宏*.碳青霉烯类抗菌药物合理用药的分析 .中国临床药理学杂志 .201.34(13) .97-99.核心期刊 |